Biogen Income Statement Analysis

Revenue, earnings, and profit margins in billions USD

Scroll to see more
Biogen Inc. income statement - Annual data in billions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Revenue & Gross Profit
Revenue9.819.689.8410.1710.9813.4414.3813.45
Cost of Revenue2.902.312.532.282.111.811.961.82
Gross Profit6.917.377.307.908.8711.6412.4211.64
Operating Expenses
Research & Development1.952.492.462.232.503.982.282.60
Selling, General & Administrative2.432.392.552.402.682.522.372.11
Operating Expenses5.044.885.014.995.446.99-5.395.64
Operating Income1.882.492.293.623.444.657.046.00
Other Income/Expense
Interest Income0.090.070.280.090.010.040.000.11
Interest Expense0.250.250.25-0.25-0.25-0.210.000.20
Other Income/Expense-0.48-0.580.320.850.000.01-0.16-0.01
Income
Income Before Tax1.401.911.303.591.785.057.135.90
Income Tax Expense0.110.270.140.630.050.991.161.43
Net Income1.291.631.163.051.564.005.894.43
Net Income - Continuous Operations1.291.631.162.961.730.000.000.00
Net Income - Discontinued Operations0.000.000.000.000.000.000.000.00
EBITDA3.103.002.074.363.925.117.536.85
EBIT2.822.341.543.843.444.657.076.10
Depreciation & Amortization0.940.670.250.270.490.46-0.490.75
Earnings Per Share
Basic EPS9.0011.008.0021.0010.0025.0031.0022.00
Diluted EPS9.0011.008.0021.0010.0025.0031.0022.00
Basic Shares Outstanding0.150.150.140.150.150.160.190.20
Diluted Shares Outstanding0.150.150.150.150.150.160.190.21